643 related articles for article (PubMed ID: 25976468)
1. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
2. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Anti-Mullerian Hormone Levels Pre- and Post-Hematopoietic Cell Transplantation in Pediatric and Adolescent Females with Sickle Cell Disease.
George SA; Lai KW; Lewis RW; Bryson EW; Haight AE; Meacham LR
Transplant Cell Ther; 2022 Nov; 28(11):770.e1-770.e6. PubMed ID: 35995392
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
5. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency.
Falorni A; Brozzetti A; Aglietti MC; Esposito R; Minarelli V; Morelli S; Sbroma Tomaro E; Marzotti S
Clin Endocrinol (Oxf); 2012 Sep; 77(3):453-8. PubMed ID: 22417127
[TBL] [Abstract][Full Text] [Related]
6. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.
La Marca A; Marzotti S; Brozzetti A; Stabile G; Artenisio AC; Bini V; Giordano R; De Bellis A; Volpe A; Falorni A;
J Clin Endocrinol Metab; 2009 Oct; 94(10):3816-23. PubMed ID: 19622621
[TBL] [Abstract][Full Text] [Related]
7. Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
Pecker LH; Hussain S; Christianson MS; Lanzkron S
Br J Haematol; 2020 Dec; 191(5):880-887. PubMed ID: 32712966
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Description of Gonadal Function in Sickle-cell Patients Treated With Hematopoietic Stem Cell Transplant Using Alkylator-based Conditioning Regimens.
Elchuri SV; Williamson Lewis R; Quarmyne MO; Haight AE; Cottrell HN; Meacham LR
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e575-e582. PubMed ID: 32205784
[TBL] [Abstract][Full Text] [Related]
9. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
10. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.
Kallio S; Aittomäki K; Piltonen T; Veijola R; Liakka A; Vaskivuo TE; Dunkel L; Tapanainen JS
Hum Reprod; 2012 Mar; 27(3):854-60. PubMed ID: 22258659
[TBL] [Abstract][Full Text] [Related]
11. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
12. Age at menarche: a predictor of diminished ovarian function?
Weghofer A; Kim A; Barad DH; Gleicher N
Fertil Steril; 2013 Oct; 100(4):1039-43. PubMed ID: 23809497
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve.
Gleicher N; Weghofer A; Barad DH
Fertil Steril; 2010 Dec; 94(7):2824-7. PubMed ID: 20538269
[TBL] [Abstract][Full Text] [Related]
14. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
Lukusa AK; Vermylen C; Vanabelle B; Curaba M; Brichard B; Chantrain C; Dupont S; Ferrant A; Wyns C
Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment.
Molinari S; Parissone F; Evasi V; De Lorenzo P; Valsecchi MG; Cesaro S; Fraschini D; Sangalli R; Cacace G; Biondi A; Balduzzi A; Cattoni A
Eur J Endocrinol; 2021 Oct; 185(5):717-728. PubMed ID: 34519276
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone deficiency in females with Fanconi anemia.
Sklavos MM; Giri N; Stratton P; Alter BP; Pinto LA
J Clin Endocrinol Metab; 2014 May; 99(5):1608-14. PubMed ID: 24438373
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydroxyurea on fertility in male and female sickle cell disease patients. A systemic review and meta-analysis.
Sewaralthahab S; Alsubki LA; Alhrabi MS; Alsultan A
PLoS One; 2024; 19(6):e0304241. PubMed ID: 38848387
[TBL] [Abstract][Full Text] [Related]
19. Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.
Kasahara Y; Osuka S; Bayasula ; Nakanishi N; Murase T; Nakamura T; Goto M; Kotani T; Iwase A; Kikkawa F
Reprod Sci; 2021 Jan; 28(1):31-36. PubMed ID: 32737737
[TBL] [Abstract][Full Text] [Related]
20. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate?
de Araujo DB; Yamakami LY; Aikawa NE; Bonfá E; Viana VS; Pasoto SG; Pereira RM; Serafin PC; Borba EF; Silva CA
Scand J Rheumatol; 2014; 43(6):503-11. PubMed ID: 24881927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
